---
title: "美國銀行證券在 TG 治療（TGTX）發佈財報後持看空態度"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/278261754.md"
description: "美國銀行證券在 TG Therapeutics, Inc.（NASDAQ:TGTX）發佈財報後重申了其 “賣出” 評級。分析師 Alec Stranahan 設定了 15 美元的目標價，這是華爾街預估中最低的。儘管該公司被列為當前最值得購買的 13 只高利潤成長股之一，但悲觀的前景反映了對公司業績的擔憂"
datetime: "2026-03-08T10:55:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278261754.md)
  - [en](https://longbridge.com/en/news/278261754.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278261754.md)
---

# 美國銀行證券在 TG 治療（TGTX）發佈財報後持看空態度

TG Therapeutics, Inc. (NASDAQ:TGTX) is one of the 13 Most Profitable Growth Stocks to Buy Right Now. Alec Stranahan of Bank of America reaffirmed a Sell rating on TG Therapeutics, Inc. (NASDAQ:TGTX) with a price target of $15, based on the report released on February 27. The firm’s price target is the lowest among Wall \[…\]

### 相關股票

- [ARKG.US](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [XLV.US](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [IBBQ.US](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [TGTX.US](https://longbridge.com/zh-HK/quote/TGTX.US.md)
- [IXJ.US](https://longbridge.com/zh-HK/quote/IXJ.US.md)

## 相關資訊與研究

- [鉅亨速報 - Factset 最新調查：Krystal Biotech Inc(KRYS-US) EPS 預估下修至 7.55 元，預估目標價為 323.00 元](https://longbridge.com/zh-HK/news/282570027.md)
- [雙雙入選 2026 SGO 口頭報告：蘆康沙妥珠單抗 (sac-TMT) 兩項婦科腫瘤研究成果發佈](https://longbridge.com/zh-HK/news/282607157.md)
- [藥廠 AI 合作潮！諾和諾德攜手 OpenAI 股價走揚](https://longbridge.com/zh-HK/news/282755292.md)
- [諾和諾德夥 OpenAI 研發藥物 AI 分析數據 識別具潛力候選藥](https://longbridge.com/zh-HK/news/282661383.md)
- [諾和諾德與 OpenAI 攜手，以 AI 加速開發肥胖與代謝藥物](https://longbridge.com/zh-HK/news/282666368.md)